Exertional dyspnoea in chronic heart failure: The role of the lung and respiratory mechanical factors

European Respiratory Review

Volumn 25, Issue 141, 2016, Pages 317-332

  Dubé, Bruno Pierre ^a   Agostoni, Piergiuseppe ^b,c   Laveneziana, Pierantonio ^d,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CATECHOLAMINE; GHRELIN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; NEUROPEPTIDE Y; RENIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD CARBON DIOXIDE TENSION; BREATHING MUSCLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; DYSPNEA; EXERCISE; EXERCISE INTENSITY; EXERCISE TEST; EXERTIONAL DYSPNEA; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEMODYNAMIC PARAMETERS; HUMAN; HYPERINFLATION; LUNG ARTERY PRESSURE; MUSCLE EXERCISE; MUSCLE FATIGUE; MUSCLE PERFUSION; MUSCLE TRAINING; OXYGEN SATURATION; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; RESPIRATORY FUNCTION; RESPIRATORY TRACT PARAMETERS; TOTAL LUNG CAPACITY; BREATHING MECHANICS; CHRONIC DISEASE; COMPLICATION; DISEASE COURSE; EXERCISE TOLERANCE; HEMODYNAMICS; LUNG; PROGNOSIS; RISK FACTOR;

CHRONIC DISEASE; DISEASE PROGRESSION; DYSPNEA; EXERCISE; EXERCISE TOLERANCE; HEART FAILURE; HEMODYNAMICS; HUMANS; LUNG; PROGNOSIS; RESPIRATORY MECHANICS; RISK FACTORS;

EID: 84986193776     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0048-2016     Document Type: Article

References (143)

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics 2016 update: a report from the American Heart Association. Circulation 2016; 133: e38-e360.
2. Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: preventing disease and death worldwide. ESC Heart Fail 2014; 1: 4-25.
3. Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J 2014; 43: 1750-1762.
4. Laveneziana P, Similowski T, Morelot-Panzini C. Multidimensional approach to dyspnea. Curr Opin Pulm Med 2015; 21: 127-132.
5. O’Donnell D, D’Arsigny C, Raj S, et al. Ventilatory assistance improves exercise endurance in stable congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1804-1811.
6. Laveneziana P, O’Donnell D, Ofir D, et al. Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure. J Appl Physiol 2009; 106: 1574-1583.
7. Agostoni PG, Marenzi GC, Pepi M, et al. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993; 21: 424-431.
8. Clark AL, Sparrow JL, Coats AJ. Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin? Eur Heart J 1995; 16: 49-52.
9. Hamilton AL, Killian KJ, Summers E, et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031.
10. Hamilton AL, Killian KJ, Summers E, et al. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest 1996; 110: 1255-1263.
11. Russell SD, McNeer FR, Higginbotham MB. Exertional dyspnea in heart failure: a symptom unrelated to pulmonary function at rest or during exercise. Duke University Clinical Cardiology Studies (DUCCS) Exercise Group. Am Heart J 1998; 135: 398-405.
12. Gandevia SC. Neural mechanisms underlying the sensation of breathlessness: kinesthetic parallels between respiratory and limb muscles. Aust N Z J Med 1988; 18: 83-91.
13. Gandevia SC, McCloskey DI. Changes in motor commands, as shown by changes in perceived heaviness, during partial curarization and peripheral anaesthesia in man. J Physiol 1977; 272: 673-689.
14. McCloskey DI, Ebeling P, Goodwin GM. Estimation of weights and tensions and apparent involvement of a "sense of effort". Exp Neurol 1974; 42: 220-232.
15. Sinoway LI, Smith MB, Enders B, et al. Role of diprotonated phosphate in evoking muscle reflex responses in cats and humans. Am J Physiol 1994; 267: H770-H778.
16. Lipkin DP, Canepa-Anson R, Stephens MR, et al. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br Heart J 1986; 55: 439-445.
17. Witte KK, Clark AL. Cycle exercise causes a lower ventilatory response to exercise in chronic heart failure. Heart 2005; 91: 225-226.
18. Apostolo A, Laveneziana P, Palange P, et al. Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure. Int J Cardiol 2015; 189: 134-140.
19. Gargiulo P, Apostolo A, Perrone-Filardi P, et al. A non invasive estimate of dead space ventilation from exercise measurements. PLoS One 2014; 9: e87395.
20. Carell ES, Murali S, Schulman DS, et al. Maximal exercise tolerance in chronic congestive heart failure. Relationship to resting left ventricular function. Chest 1994; 106: 1746-1752.
21. Clark AL, Swan JW, Laney R, et al. The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure. Circulation 1994; 89: 2062-2069.
22. Davies SW, Fussell AL, Jordan SL, et al. Abnormal diastolic filling patterns in chronic heart failure: relationship to exercise capacity. Eur Heart J 1992; 13: 749-757.
23. Higginbotham MB, Morris KG, Conn EH, et al. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 1983; 51: 52-60.
24. Witte KK, Nikitin NP, De Silva R, et al. Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure. Heart 2004; 90: 1144-1150.
25. Benge W, Litchfield RL, Marcus ML. Exercise capacity in patients with severe left ventricular dysfunction. Circulation 1980; 61: 955-959.
26. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981; 47: 33-39.
27. Wilson JR, Rayos G, Yeoh TK, et al. Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates. J Am Coll Cardiol 1995; 26: 429-435.
28. Ciampi Q, Pratali L, Porta MD, et al. Tissue Doppler systolic velocity change during dobutamine stress echocardiography predicts contractile reserve and exercise tolerance in patients with heart failure. Eur Heart J Cardiovasc Imaging 2013; 14: 102-109.
29. Gibbs JS, Keegan J, Wright C, et al. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol 1990; 15: 52-61.
30. Szlachcic J, Massie BM, Kramer BL, et al. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985; 55: 1037-1042.
31. Ribeiro JP, White HD, Arnold JM, et al. Exercise responses before and after long-term treatment with oral milrinone in patients with severe heart failure. Am J Med 1986; 81: 759-764.
32. Wilson JR, Martin JL, Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 1984; 53: 1308-1315.
33. Franciosa JA, Cohn JN. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. Am J Cardiol 1979; 43: 1009-1014.
34. Redfield MM, Chen HH, Borlaug BA, et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2013; 309: 1268-1277.
35. Guazzi M, Marenzi G, Alimento M, et al. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997; 95: 1930-1936.
36. Agostoni P, Magini A, Andreini D, et al. Spironolactone improves lung diffusion in chronic heart failure. Eur Heart J 2005; 26: 159-164.
37. Laveneziana P, Agostoni P, Mignatti A, et al. Effect of acute β-blocker withholding on ventilatory efficiency in patients with advanced chronic heart failure. J Card Fail 2010; 16: 548-555.
38. Contini M, Apostolo A, Cattadori G, et al. Multiparametric comparison of CARvedilol, versus NEbivolol, versus BIsoprolol in moderate heart failure: the CARNEBI trial. Int J Cardiol 2013; 168: 2134-2140.
39. Agostoni P, Cattadori G, Guazzi M, et al. Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure. Am Heart J 2000; 140: e24.
40. Agostoni P, Bussotti M, Cattadori G, et al. Gas diffusion and alveolar-capillary unit in chronic heart failure. Eur Heart J 2006; 27: 2538-2543.
41. Kleber FX, Vietzke G, Wernecke KD, et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000; 101: 2803-2809.
42. Clark AL, Volterrani M, Swan JW, et al. The increased ventilatory response to exercise in chronic heart failure: relation to pulmonary pathology. Heart 1997; 77: 138-146.
43. Clark AL, Volterrani M, Swan JW, et al. Ventilation-perfusion matching in chronic heart failure. Int J Cardiol 1995; 48: 259-270.
44. Wasserman K, Zhang YY, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997; 96: 2221-2227.
45. Kraemer MD, Kubo SH, Rector TS, et al. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol 1993; 21: 641-648.
46. Ingle L, Shelton RJ, Cleland JG, et al. Poor relationship between exercise capacity and spirometric measurements in patients with more symptomatic heart failure. J Card Fail 2005; 11: 619-623.
47. Agostoni P, Pellegrino R, Conca C, et al. Exercise hyperpnea in chronic heart failure: relationships to lung stiffness and expiratory flow limitation. J Appl Physiol 2002; 92: 1409-1416.
48. Christie RV, Meakins JC. The intrapleural pressure in congestive heart failure and its clinical significance. J Clin Invest 1934; 13: 323-345.
49. Evans SA, Watson L, Cowley AJ, et al. Static lung compliance in chronic heart failure: relation with dyspnoea and exercise capacity. Thorax 1995; 50: 245-248.
50. Saxton GA, Rabinowitz M, Dexter L, et al. The relationship of pulmonary compliance to pulmonary vascular pressures in patients with heart disease. J Clin Invest 1956; 35: 611-618.
51. Frank NR, Lyons HA, Siebens AA, et al. Pulmonary compliance in patients with cardiac disease. Am J Med 1957; 22: 516-523.
52. Ries AL, Gregoratos G, Friedman PJ, et al. Pulmonary function tests in the detection of left heart failure: correlation with pulmonary artery wedge pressure. Respiration 1986; 49: 241-250.
53. Duguet A, Tantucci C, Lozinguez O, et al. Expiratory flow limitation as a determinant of orthopnea in acute left heart failure. J Am Coll Cardiol 2000; 35: 690-700.
54. Cabanes LR, Weber SN, Matran R, et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med 1989; 320: 1317-1322.
55. Light RW, George RB. Serial pulmonary function in patients with acute heart failure. Arch Intern Med 1983; 143: 429-433.
56. Guazzi M, Agostoni P, Matturri M, et al. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol. Am Heart J 1999; 138: 460-467.
57. Drexler H, Riede U, Munzel T, et al. Alterations of skeletal muscle in chronic heart failure. Circulation 1992; 85: 1751-1759.
58. D’Arsigny C, Webb KA, Raj S, et al. Ventilatory constraints contribute to exercise limitation and dyspnea in stable congestive heart failure. Am J Respir Crit Care Med 1999; 159: A418.
59. Agostoni PG, Marenzi GC, Sganzerla P, et al. Lung-heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure. Am J Cardiol 1995; 76: 793-798.
60. Papazachou O, Anastasiou-Nana M, Sakellariou D, et al. Pulmonary function at peak exercise in patients with chronic heart failure. Int J Cardiol 2007; 118: 28-35.
61. Dall’Ago P, Chiappa GR, Guths H, et al. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol 2006; 47: 757-763.
62. McConnell AK, Lomax M. The influence of inspiratory muscle work history and specific inspiratory muscle training upon human limb muscle fatigue. J Physiol 2006; 577: 445-457.
63. Uren NG, Davies SW, Jordan SL, et al. Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure. Eur Heart J 1993; 14: 744-750.
64. Borghi-Silva A, Carrascosa C, Oliveira CC, et al. Effects of respiratory muscle unloading on leg muscle oxygenation and blood volume during high-intensity exercise in chronic heart failure. Am J Physiol Heart Circ Physiol 2008; 294: H2465-H2472.
65. Nanas S, Nanas J, Papazachou O, et al. Resting lung function and hemodynamic parameters as predictors of exercise capacity in patients with chronic heart failure. Chest 2003; 123: 1386-1393.
66. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988; 77: 552-559.
67. Wada O, Asanoi H, Miyagi K, et al. Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure. Am Heart J 1993; 125: 790-798.
68. Metra M, Dei Cas L, Panina G, et al. Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics. Am J Cardiol 1992; 70: 622-628.
69. Clark AL, Coats AJ. Exercise hyperventilation chronic congestive heart failure and its relation to functional capacity and hemodynamics. Am J Cardiol 1993; 71: 1007-1008.
70. Clark AL, Coats AJ. Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure. Br Heart J 1994; 71: 528-530.
71. Puri S, Baker BL, Dutka DP, et al. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation 1995; 91: 2769-2774.
72. Guazzi M, Agostoni P, Bussotti M, et al. Impeded alveolar-capillary gas transfer with saline infusion in heart failure. Hypertension 1999; 34: 1202-1207.
73. Agostoni P, Cattadori G, Bianchi M, et al. Exercise-induced pulmonary edema in heart failure. Circulation 2003; 108: 2666-2671.
74. Paolillo S, Pellegrino R, Salvioni E, et al. Role of alveolar β2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans. PloS One 2013; 8: e61877.
75. Robertson HT, Pellegrino R, Pini D, et al. Exercise response after rapid intravenous infusion of saline in healthy humans. J Appl Physiol (1985) 2004; 97: 697-703.
76. Agostoni PG, Guazzi M, Bussotti M, et al. Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. J Am Coll Cardiol 2000; 36: 1600-1604.
77. Kay JM, Edwards FR. Ultrastructure of the alveolar-capillary wall in mitral stenosis. J Pathol 1973; 111: 239-245.
78. Guazzi M, Pontone G, Brambilla R, et al. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J 2002; 23: 467-476.
79. Guazzi M, Palermo P, Pontone G, et al. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure. Am J Cardiol 1999; 84: 1038-1043.
80. Chugh SS, Chua TP, Coats AJ. Peripheral chemoreflex in chronic heart failure: friend and foe. Am Heart J 1996; 132: 900-904.
81. Sun SY, Wang W, Zucker IH, et al. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 1999; 86: 1264-1272.
82. Sun SY, Wang W, Zucker IH, et al. Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 1999; 86: 1273-1282.
83. Chua TP, Clark AL, Amadi AA, et al. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996; 27: 650-657.
84. Chua TP, Ponikowski P, Webb-Peploe K, et al. Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. Eur Heart J 1997; 18: 480-486.
85. Weber KT, Kinasewitz GT, Janicki JS, et al. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982; 65: 1213-1223.
86. Franciosa JA, Leddy CL, Wilen M, et al. Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. Am J Cardiol 1984; 53: 127-134.
87. Chua TP, Ponikowski P, Harrington D, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997; 29: 1585-1590.
88. Johnson RL Jr. Gas exchange efficiency in congestive heart failure II. Circulation 2001; 103: 916-918.
89. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103: 967-972.
90. Piepoli M, Clark AL, Volterrani M, et al. Contribution of muscle afferents to the hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure: effects of physical training. Circulation 1996; 93: 940-952.
91. Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med 2004; 36: 518-529.
92. Steinborn W, Anker SD. Cardiac Cachexia: Pathophysiology and Clinical Implications. Basic Appl Myol 2003; 13: 191-201.
93. Nicoletti I, Cicoira M, Zanolla L, et al. Skeletal muscle abnormalities in chronic heart failure patients: relation to exercise capacity and therapeutic implications. Congest Heart Fail 2003; 9: 148-154.
94. Minotti JR, Pillay P, Oka R, et al. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 1993; 75: 373-381.
95. Nilsson KR, Duscha BD, Hranitzky PM, et al. Chronic heart failure and exercise intolerance: the hemodynamic paradox. Curr Cardiol Rev 2008; 4: 92-100.
96. Schaufelberger M, Eriksson BO, Grimby G, et al. Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J 1997; 18: 971-980.
97. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990; 81: 518-527.
98. Lipkin DP, Jones DA, Round JM, et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988; 18: 187-195.
99. Massie BM, Conway M, Rajagopalan B, et al. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation 1988; 78: 320-326.
100. Massie B, Conway M, Yonge R, et al. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 1987; 76: 1009-1019.
101. Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999; 20: 683-693.
102. Hambrecht R, Schulze PC, Gielen S, et al. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 1175-1181.
103. Niebauer J, Pflaum CD, Clark AL, et al. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 1998; 32: 393-397.
104. Volterrani M, Clark AL, Ludman PF, et al. Predictors of exercise capacity in chronic heart failure. Eur Heart J 1994; 15: 801-809.
105. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 1993; 87: 470-475.
106. Duscha BD, Annex BH, Green HJ, et al. Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol 2002; 39: 1170-1174.
107. Vescovo G, Serafini F, Facchin L, et al. Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. Heart 1996; 76: 337-343.
108. Adreani CM, Hill JM, Kaufman MP. Responses of group III and IV muscle afferents to dynamic exercise. J Appl Physiol 1997; 82: 1811-1817.
109. Piepoli MF, Kaczmarek A, Francis DP, et al. Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure. Circulation 2006; 114: 126-134.
110. Ponikowski PP, Chua TP, Francis DP, et al. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation 2001; 104: 2324-2330.
111. Scott AC, Francis DP, Davies LC, et al. Contribution of skeletal muscle ‘ergoreceptors’ in the human leg to respiratory control in chronic heart failure. J Physiol 2000; 529 Pt 3: 863-870.
112. Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992; 85: 2119-2131.
113. Hughes PD, Polkey MI, Harrus ML, et al. Diaphragm strength in chronic heart failure. Am J Respir Crit Care Med 1999; 160: 529-534.
114. Granton JT, Naughton MT, Benard DC, et al. CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1996; 153: 277-282.
115. Daganou M, Dimopoulou I, Alivizatos PA, et al. Pulmonary function and respiratory muscle strength in chronic heart failure: comparison between ischaemic and idiopathic dilated cardiomyopathy. Heart 1999; 81: 618-620.
116. Hammond MD, Bauer KA, Sharp JT, et al. Respiratory muscle strength in congestive heart failure. Chest 1990; 98: 1091-1094.
117. McParland C, Krishnan B, Wang Y, et al. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis 1992; 146: 467-472.
118. Ambrosino N, Opasich C, Crotti P, et al. Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure. Eur Respir J 1994; 7: 17-22.
119. Nishimura Y, Maeda H, Tanaka K, et al. Respiratory muscle strength and hemodynamics in chronic heart failure. Chest 1994; 105: 355-359.
120. Evans SA, Watson L, Hawkins M, et al. Respiratory muscle strength in chronic heart failure. Thorax 1995; 50: 625-628.
121. Kasahara Y, Izawa KP, Watanabe S, et al. The relation of respiratory muscle strength to disease severity and abnormal ventilation during exercise in chronic heart failure patients. Res Cardiovasc Med 2015; 4: e28944.
122. Frankenstein L, Meyer FJ, Sigg C, et al. Is serial determination of inspiratory muscle strength a useful prognostic marker in chronic heart failure? Eur J Cardiovasc Prev Rehabil 2008; 15: 156-161.
123. Callegaro CC, Martinez D, Ribeiro PA, et al. Augmented peripheral chemoreflex in patients with heart failure and inspiratory muscle weakness. Respir Physiol Neurobiol 2010; 171: 31-35.
124. St Croix CM, Morgan BJ, Wetter TJ, et al. Fatiguing inspiratory muscle work causes reflex sympathetic activation in humans. J Physiol 2000; 529 Pt 2: 493-504.
125. Mancini DM, Henson D, LaManca J, et al. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992; 86: 909-918.
126. Musch TI. Elevated diaphragmatic blood flow during submaximal exercise in rats with chronic heart failure. Am J Physiol 1993; 265: H1721-H1726.
127. Johnson BD, Beck KC, Olson LJ, et al. Ventilatory constraints during exercise in patients with chronic heart failure. Chest 2000; 117: 321-332.
128. Aubier M, Trippenbach T, Roussos C. Respiratory muscle fatigue during cardiogenic shock. J Appl Physiol Respir Environ Exerc Physiol 1981; 51: 499-508.
129. Nanas S, Nanas J, Kassiotis C, et al. Respiratory muscles performance is related to oxygen kinetics during maximal exercise and early recovery in patients with congestive heart failure. Circulation 1999; 100: 503-508.
130. Mancini DM, Henson D, LaManca J, et al. Evidence of reduced respiratory muscle endurance in patients with heart failure. J Am Coll Cardiol 1994; 24: 972-981.
131. Supinski G, DiMarco A, Dibner-Dunlap M. Alterations in diaphragm strength and fatiguability in congestive heart failure. J Appl Physiol 1994; 76: 2707-2713.
132. Lenique F, Habis M, Lofaso F, et al. Ventilatory and hemodynamic effects of continuous positive airway pressure in left heart failure. Am J Respir Crit Care Med 1997; 155: 500-505.
133. Lecarpentier Y, Coirault C, Lerebours G, et al. Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain. Am J Respir Crit Care Med 1997; 155: 630-636.
134. Sieck GC, Fournier M. Diaphragm motor unit recruitment during ventilatory and nonventilatory behaviors. J Appl Physiol 1989; 66: 2539-2545.
135. Tikunov B, Levine S, Mancini D. Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation 1997; 95: 910-916.
136. Lindsay DC, Lovegrove CA, Dunn MJ, et al. Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J 1996; 17: 1239-1250.
137. Howell S, Maarek JM, Fournier M, et al. Congestive heart failure: differential adaptation of the diaphragm and latissimus dorsi. J Appl Physiol 1995; 79: 389-397.
138. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 1996; 335: 1897-1905.
139. Mancini DM, Ferraro N, Nazzaro D, et al. Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy. J Am Coll Cardiol 1991; 18: 492-498.
140. Terakado S, Takeuchi T, Miura T, et al. Early occurrence of respiratory muscle deoxygenation assessed by near-infrared spectroscopy during leg exercise in patients with chronic heart failure. Jpn Circ J 1999; 63: 97-103.
141. Mancini DM, Henson D, La Manca J, et al. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart failure. Circulation 1995; 91: 320-329.
142. Johnson PH, Cowley AJ, Kinnear WJ. A randomized controlled trial of inspiratory muscle training in stable chronic heart failure. Eur Heart J 1998; 19: 1249-1253.
143. Winkelmann ER, Chiappa GR, Lima CO, et al. Addition of inspiratory muscle training to aerobic training improves cardiorespiratory responses to exercise in patients with heart failure and inspiratory muscle weakness. Am Heart J 2009; 158: 768-767.